Sage Journals: Discover world-class research

Abstract

Our previous studies have shown two distinct disease patterns (rapid and normal onset of clinical symptoms) in morphine-dependent SHIV/SIV-inoculated rhesus macaques. We have also shown that control as well as 50% of morphine-dependent macaques (normal progressor) developed humoral and cellular immune responses whereas the other half of the morphine-dependent macaques (rapid progressor) did not develop antiviral immune responses after infection with SIV/SHIV. In the present study, we analyzed the association between cytokine production, immune response, and disease progression. To study the immunological effects of morphine at cytokine levels in the context of a lentiviral infection, we inoculated rhesus macaques with a mixture of SHIV_KU−18, SHIV_89.6P, and SIV/17E-Fr. These animals were followed for a period of 56 weeks for cytokine level production in plasma. Drug-dependent rapid disease progressors exhibited an increase in IL-18 and IL-1Ra and a decrease in IL-12 levels in the plasma. Morphine-dependent normal progressors and control macaques exhibited an increase in both IL-18 and IL-12, whereas IL-Ra levels remained constant throughout the observation period. These results suggest that rapid disease progression in relation to morphine dependency may be the result of an altered cytokine profile.

Get full access to this article

View all access options for this article.

References

CDC. HIV diagnosis among injection drug-users in states with HIV surveillance-25 states 1994–2000. MMWR Morb Mortal Wkly Rep, 2003; 52:3.

Chu

, Levy

. Injection drug use and HIV/AIDS transmission in China. Cell Res, 2005; 15,11–12:865–869.

Kerr

. Injection drug use fuels HIV/AIDS epidemic across Eurasia. Lancet Infect Dis, 2005; 5,9:539.

Qian

, Schumacher

, Chen

, Ruan

. Injection drug use and HIV/AIDS in China: Review of current situation, prevention and policy implications. Harm Reduct J, 2006; 3:4.

Cohn

. HIV-1 infection in injection drug users. Infect Dis Clin North Am, 2002; 16,3:745–770.

Kumar

, Orsoni

, Norman

et al. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology, 2006; 354,1:192–206.

Baker

, Block

, Rothchild

, Walker

. Elite control of HIV infection: Implications for vaccine design. Expert Opin Biol Ther, 2009; 9,1:55–69.

Holan

, Zajicova

, Krulova

, Blahoutova

, Wilczek

. Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice. Clin Exp Immunol, 2003; 132,1:40–45.

Matta

, Saphier

, Lysle

, Sharp

. The brain-immune axis: Role of opiates and other substances of abuse, the hypothalamic-pituitary-adrenal axis and behavior. Adv Exp Med Biol, 1995; 373:1–9.

10.

Kumar

, Torres

, Yamamura

et al. Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol, 2004; 78,20:11425–11428.

11.

Singh

, McCormick

, Pacyniak

et al. Pathogenic and nef-interrupted simian-human immunodeficiency viruses traffic to the macaque CNS and cause astrocytosis early after inoculation. Virology, 2002; 296,1:39–51.

12.

Reimann

, Li

, Voss

et al. An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys. J Virol, 1996; 70,5:3198–3206.

13.

Flaherty

, Hauer

, Mankowski

, Zink

, Clements

. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol, 1997; 71,8:5790–5798.

14.

Giavedoni

. Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology. J Immunol Methods, 2005; 301,1–2:89–101.

15.

Langrish

, McKenzie

, Wilson

, de Waal Malefyt

, Kastelein

, Cua

. IL-12 and IL-23: Master regulators of innate and adaptive immunity. Immunol Rev, 2004; 202:96–105.

16.

Iannello

, Samarani

, Debbeche

et al. Potential role of IL-18 in the immunopathogenesis of AIDS, HIV-associated lipodystrophy and related clinical conditions. Curr HIV Res, 2010; 8,2:147–164.

17.

Iannello

, Samarani

, Debbeche

et al. Role of interleukin-18 in the development and pathogenesis of AIDS. AIDS Rev, 2009; 11,3:115–125.

18.

Barksby

, Lea

, Preshaw

, Taylor

. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol, 2007; 149,2:217–225.

19.

Rimaniol

, Zylberberg

, Zavala

, Viard

. Inflammatory cytokines and inhibitors in HIV infection: Correlation between interleukin-1 receptor antagonist and weight loss. AIDS, 1996; 10,12:1349–1356.

20.

Kreuzer

, Dayer

, Rockstroh

, Sauerbruch

, Spengler

. The IL-1 system in HIV infection: Peripheral concentrations of IL-1beta, IL-1 receptor antagonist and soluble IL-1 receptor type II. Clin Exp Immunol, 1997; 109,1:54–58.

Short Communication: Lack of Immune Response in Rapid Progressor Morphine-Dependent and SIV/SHIV-Infected Rhesus Macaques Is Correlated with Downregulation of T H 1 Cytokines

Abstract

Get full access to this article

References